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ABSTRACT
T cell activation is a well-established model for studying cellular responses to exogenous stimulation. Using strand-specific RNA-seq, we observed that intron retention is prevalent in polyadenylated transcripts in resting CD4+ T cells and is significantly
reduced upon T cell activation. Several lines of evidence suggest that intron-retained transcripts are
less stable than fully spliced transcripts. Strikingly,
the decrease in intron retention (IR) levels correlate
with the increase in steady-state mRNA levels. Further, the majority of the genes upregulated in activated T cells are accompanied by a significant reduction in IR. Of these 1583 genes, 185 genes are
predominantly regulated at the IR level, and highly
enriched in the proteasome pathway, which is essential for proper T cell proliferation and cytokine release. These observations were corroborated in both
human and mouse CD4+ T cells. Our study revealed
a novel post-transcriptional regulatory mechanism
that may potentially contribute to coordinated and/or
quick cellular responses to extracellular stimuli such
as an acute infection.
INTRODUCTION
T cell activation is an essential step in immune response
(1,2). Upon receiving appropriate signals, resting T cells
transform from a relatively quiescent state to an active proliferation state, producing cytokines (2). The activation pro-

cess involves a coordinated program of gene expression regulation. Transcriptional regulation has been known to play
an important role in the activation process. Activator protein 1 (AP-1), nuclear factor of activated T-cells (NFAT)
and nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-B) are among the essential transcriptional regulators responsible for the induction of a battery of genes
including key cytokines such as interlukin-2 (IL2) (3,4).
The role of chromatin in T cell biology especially the activation process has attracted considerable interests. In fact,
T cell was one of the first model systems that was used to depict a comprehensive picture of the epigenome had been depicted using ChIP-seq (chromatin immunoprecipitation followed by deep sequencing) (5–7). These studies along with
studies in other systems have established epigenetic landscape as a powerful tool for annotating functional elements
involved in the regulation and execution of transcriptional
events (7,8). For example, expressed genes are enriched with
trimethylation of histone H3 at lysine 4 (H3K4me3), histone acetylations and RNA polymerase II (Pol II) at the
promoter; and trimethylation of histone H3 at lysine 36
(H3K36me3) in the transcribed regions. Beyond simple absence and presence, the levels of many histone modifications
correlate well with their gene expression levels (9). As a result, it is expected that up-regulated (down-regulated) genes
on average would exhibit a concomitant increase (decrease)
of active histone modification marks that has indeed been
observed in many systems (6,9,10).
Interestingly, recent genome-wide studies (11,12) in T cell
activation had led to a number of unexpected observations.
First of all, many inducible genes that are silent in resting
cells, have already been primed with higher levels of active
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chromatin marks (e.g. H3K4me3, H2A.Z and H3K9ac), as
well as higher levels of Pol II at the promoter. Secondly, following T cell activation, little or no change in chromatin
states was detected upon gene induction (11,12). These observations have led to the hypothesis that those genes are
‘poised’ for rapid transcription upon stimulation. However,
the discordance between histone modification levels and
gene expression levels, as well as the lack of dynamical
changes in the histone modification levels upon gene induction, is not limited to silent genes. Similar observations have
also been made in a number of rapidly induced primary response genes that have low basal expressions in resting cells
(13). These results suggest that a transcription-independent
regulatory mechanism might play a significant role during
T cell activation.
IR is one of the major forms of alternative splicing in eukaryotes (14–17). Recent studies show that IR or ‘detained’
introns could be found in diverse human and mouse tissues,
and progressively accumulate during development and terminal erythropoiesis (18–20). The functional involvement
of IR in gene regulation has drawn attention only until recently (19,21–24). In yeast, IR has been reported to coordinate the expression of ribosomal proteins and genes
related to meiotic processes (25,26). In higher eukaryotes,
gene regulation mediated by intron retention has been observed during neurogenesis (23), granulocyte differentiation
(21) and terminal erythropoiesis (20). However, it is unknown whether IR is regulated during cell stimulation such
as T cell activation.
In this study, we found that IR is prevalent in resting
CD4+ T cells and dramatically decrease upon cell activation. We provide evidence that transcripts with retained introns are less stable, implying the potential coupling between IR and RNA degradation in dialing up/down gene
expression. The reduction of IR has a striking correlation with increased expression of their corresponding genes
upon T cell activation. Furthermore, we identified a subset of genes whose expressions are mainly regulated via IR.
These genes are highly enriched in proteasome genes that
are known to be involved in T cell proliferation and cytokine
release. Regulated IR was also observed in primary mouse
CD4+ T cells upon activation. Taken together, we propose
that IR, in combination with RNA degradation, serves as a
novel post-transcriptional mechanism broadly involved in
regulating gene expression during CD4+ T cell activation.

reagent (Invitrogen). The resulting RNA was further purified with the RNeasy mini kit (Qiagen) and an on-column
DNase I treatment to eliminate DNA contamination.
Library construction
The human CD4+ T cell RNA-seq libraries were constructed according to the DeLi-seq protocol, a strandspecific RNA-seq procedure (27). All RNA samples were
subjected to two rounds of polyA+ RNA selection with
oligo(dT)25 Dynabeads (Invitrogen) before library construction. ChIP-seq libraries were constructed as previously described (5,7). ChIP grade antibodies for Pol II
and H3K36me3 were purchased from Abcam with cat.
no. ab26721 and ab9050, respectively. All libraries were sequenced using an Illumina HiSeq 2000 sequencer, and the
data sets used in this study are summarized in Supplementary Table S6.
Sequence alignment
For the human CD4+ T cell RNA-seq and ChIP-seq libraries, we performed single-end mapping using BWA (28)
with default parameters against human genome hg19. For
the mouse CD4+ T cell RNA-seq libraries, we performed
paired-end mapping using BWA with default parameters
against mouse genome mm9. Only uniquely mapped reads
were used for downstream analyses.
Compilation of gene model
We utilized an annotation system where each gene is represented by its Entrez ID and the associated isoforms are
represented by their RefSeq IDs. To reliably calculate the
IR levels, it is critical to minimize potential biases due to
alternative designation of introns (or exons) in multiple isoforms. To this end, transcript isoforms were consolidated
and only the shared intronic (exonic) regions in all annotated isoforms are designated as intronic (exonic) regions
(Supplementary Figure S3). In addition, Entrez genes were
removed from the analysis if they had one of the following issues: (i) contained one or more NR transcripts (noncoding transcripts in the RefSeq annotation system); or (ii)
contained two or more transcripts that do not overlap or
on different strands; or (iii) overlapped with another gene
on the same strand; or (iv) had no intron.

MATERIALS AND METHODS
CD4+ T cell isolation and activation
+

Human CD4 T cells were isolated from peripheral blood
monocytes using the Dynabeads Untouched Human CD4
T Cells kit (Invitrogen) as previously described (5). CD4+
T cell activation was performed with the Dynabeads Human T-Activator CD3/CD28 for T-Cell Expansion and Activation kit (Invitrogen) by incubating them at 37◦ C for 18
hours (h). The cell morphology was observed under the microscope, and CD25, a cell surface marker, was used to confirm T cell activation by fluorescence activated cell sorting
(FACS). Mouse CD4+ T cells were isolated from the lymph
nodes, and activated with the CD3/CD28 antibody for a period of 8, 12 or 24 h. Total RNA was isolated using TRIzol

Calculation of intron retention index
The intron retention index (IRI) is devised to quantify the
extent of IR based on the gene model defined above. Specifically, the IRI of a gene is defined as the ratio of read density
of shared intronic regions and that of shared exonic regions.
Since the RefSeq and Entrez annotation system is unlikely
to include all the genes and isoforms, we removed genes
whose IRI > 1 in either resting or activated states from further analysis to reduce the negative impact due to missing
annotations. In genes with low expression levels, the IRI values are more susceptible to statistical errors. Therefore, in
downstream analysis that involves genes characterized by
IRI, only genes expressed in resting state (RPKM > 1) were
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Figure 1. Intron retention (IR) is prevalent in resting human CD4+ T cells and dramatically reduced upon activation. (A) The transcriptomes of human
resting and activated CD4+ T cells were profiled by RNA-seq. Oligo(dT) was used to enrich polyA+ RNAs, which were sequenced using DeLi-seq, a
strand-specific RNA-seq procedure. The normalized expression profiles of a candidate gene, PSMD12, are shown in the bottom panel. Two representative
introns with differential IR between resting and activated T cells are shown in dashed rectangle. (B) The fraction of intronic reads in total mapped reads
are shown for resting and activated T cells. Compared to resting T cells, activated T cells show a significantly reduced fraction of intronic reads (P-value <
1 × 10−300 , X2 test). (C) The frequency density distribution of IR Index (IRI) of individual genes in resting and activated human T cells. The integral of
the area under the vertical bars is 1 for both resting and activated T cells. For each gene locus, IRI is defined as the ratio of normalized tag density between
shared introns and shared exons. The mean and median IRI for the resting condition is 7.1% and 4.0%, respectively, whereas the mean and median IRI for
the activated condition is 3.8% and 1.8%, respectively.

used. Furthermore, in the IRI histograms shown in Figure
1C and Supplementary Figure S5B, only genes expressed
(shared exonic RPKM ≥ 1) in resting state and those with
an IRI > 0 in both states are included.
Calculation of IR percentage
An alternative strategy to characterize IR is to use reads
covering splice junctions. We define a constitutive junction
as an annotated splice junction that connects a shared intronic region and a shared exonic region. To remove ambiguity, we only examine annotated constitutive junctions. We
consider a read to be across-junction if it covers the junction
point and overlaps both sides for at least 8 bp. We consider
a read to be spliced if its coverage jumps over the junction
point and overlaps the shared exonic region for at least 8
bp. Genome-wide, we calculate the intron retention percentage (IRP) as the fraction of all junction reads (i.e. acrossjunction + spliced) that are across-junction. For each gene,

intron retention ratio is defined in a similar manner, with
the constitutive junctions limited to those belonging to this
gene. For other reads, only those overlapping with upstream
exon for at least 8 bp were included in the IRP calculation.
In Supplementary Figure S4B, only genes that are used in
Figure 1C are included. Furthermore, genes with zero exon–
intron reads or zero exon–exon reads in either resting or activated state are excluded.

RNA-seq analysis
Differentially expressed genes were selected by requiring a
fold change (FC) > 2 and a reads per kilobase per million
(RPKM) in shared exons > 1 in the state with higher expression.
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ChIP-seq analysis
To eliminate background noise in ChIP-seq data sets,
SICER was used to determine ChIP-enriched regions for
each sample (29). Only reads for ChIP-enriched regions
were used for downstream analysis. For all ChIP-seq libraries, the window size was chosen to be 200 bp. For histone modifications H3K36me3 and H4K20me1, the gap
size was chosen to be 600 bp. For histone modification
H3K4me3, the gap size was chosen to be 200 bp. For RNA
Pol II, the gap size was chosen to be 400 bp. In all cases, the
false discovery rate (FDR) was chosen to be 0.01.

was adjusted based on the gene-specific primers used. Melting curve module was included in the StepOnePlus RT-PCR
system (Applied Biosystems).
ChIP-PCR validation of candidate genes
ChIP coupled with PCR assays were performed as described previously (30). Monoclonal anti-Pol II (ab76123,
Abcam) antibody was used for immunoprecipitation.
Primers for PSMD7 and STAT1 genes are listed in Supplementary Table S5.

Gene ontology analysis

RESULTS

Gene ontology analysis was carried out using the GeneRank program with default settings in the Genomatix
Genome Analyzer (GGA) package.

Prevalent IR in human resting T cells compared with activated T cells

RT-PCR validation of retained introns
We performed reverse transcription followed by polymerase
chain reaction (RT-PCR) to validate the intron retention ratio change upon T cell activation. Primer pair
in the upstream exon and downstream exon was used
for detection of gene expression. Primer pair in the upstream exon and downstream intron was used to reflect
the IR signal. Primers were designed by Primer3 (version
0.4.0) and synthesized by IDT. Reverse transcription of
1 g DNA-free total RNA was performed with SuperScript II reverse transcriptase (Invitrogen) in a 20 l reaction, containing 1x first strand synthesis buffer (Invitrogen), 5 M dNTP (Bioline), 0.5 M oligo(dT) primer (5 TTTTTTTTTTTTTTTTTTTTVN-3 ; V = A/C/G and N
= A/C/G/T), 10 mM DTT, 40 units of RNasin (Promega)
and 200 units of SuperScript II Reverse Transcriptase (Invitrogen). The RT reaction was incubated at 42◦ C for 2
minitues (min) before adding reverse transcriptase. We then
incubated the reaction at 42◦ C for 60 min and 75◦ C for 15
min. The 20 l PCR reaction contains 1 l of RT template,
1x PCR buffer (Qiagen), 0.4 nmol dNTP, 0.2 M of the forward primer and two reverse primers (one is for exon signal
and the other is for intron signal) and 1 l of Taq DNA
Polymerase (Qiagen). Thermal cycling was carried out as
follows: 94◦ C for 30 seconds (s); 30–40 cycles of 94◦ C for 30
s, 52–58◦ C for 30 s and 72◦ C for 30 s; 72◦ C for 10 min; hold
at 4◦ C. A total of 3 l of PCR product was taken out and
run in a 2% agarose gel (Invitrogen EX E-gel). The PCR
cycle number is adjusted according to the gene expression
and the annealing temperature is adjusted according to the
gene-specific primers used.
Quantitative real-time PCR validation of retained introns
The reverse transcription reaction for regular RT-PCR was
also used for quantitative PCR (qPCR). The 20 l qPCR
reaction contains 0.5 l RT reaction (cDNA template), 0.2
M of the forward primer and the reverse primer and 10
l 2x SYBR Green Power Mix (ABI). The qPCR reaction
was prepared in triplicates. Thermal cycling was carried out
as follows: 95◦ C for 10 min; 40 cycles of 95◦ C for 15 s, 52–
58◦ C for 30 s and 72◦ C for 30 s. The annealing temperature

We employed DeLi-seq, a strand-specific RNA-seq procedure based on directional ligation of two adaptors to the
double-stranded cDNA (27), to characterize transcriptome
profiles of human CD4+ T cells before and after activation.
Consistent with previous findings (11,12), we did not find
concordant changes of active mark H3K4me3 in genes that
were up- or down-regulated upon T cell activation (Supplementary Figure S1). This is in sharp contrast to genes differentially expressed during hematopoietic stem cell differentiation (Supplementary Figure S1A and B), suggesting that
mechanism(s) other than transcriptional regulation might
be involved in controlling gene expression during T cell activation.
A close examination of the RNA-seq data, however, revealed that a significant number of reads reside in intronic
regions. This is unexpected because polyA+ transcripts
were used for constructing RNA-seq libraries (Figure 1).
Strikingly, the phenomenon is more pronounced in resting
T cells; the proportion of intronic reads is significantly reduced after T cell activation (15.1% versus 7.3%, P-value
< 1E-300, chi-squared test, Figure 1B). Because strandspecific RNA-seq was used to produce the transcriptome
profile, one can largely rule out that these intronic reads result from antisense transcripts (Supplementary Figure S2)
(27). To characterize IR at the individual gene level, we devised an IRI that computes the ratio between normalized
read counts at intronic and exonic regions based on a consolidated gene model (Supplementary Figure S3, see Materials and Methods for details). The resulting IRI distributions show that IR is a prevalent phenomenon in resting T cells, and is dramatically reduced upon T cell activation (Figure 1C, P-value < 1E-300, Mann–Whitney U
test). The median value of the IRI is 4.0% in resting T cells
and decreases to 1.8% in activated T cells (Figure 1C). In
resting cells, the median IRI values for the top and bottom
1000 intron-retained genes are 20.0% and 0.62%, respectively. An alternative strategy, which characterizes IR using
exon–intron and exon–exon junction reads (19), confirmed
these findings (Supplementary Figures S4A and B). To ascertain the reproducibility of the stimulation-induced reduction in IR, we carried out DeLi-seq with resting and activated CD4+ T cells isolated from another blood donor. In
agreement with our initial observation, the results showed
that the percentage of intronic reads is significantly reduced
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after T cell activation (19.8% versus 8.5%, P-value < 1E300, chi-squared test, Supplementary Figure S5A). In addition, the IRI distribution also showed a significant shift
to a lower level (Supplementary Figure S5B), suggesting a
global reduction of IR upon activation.
IR is associated with transcript instability
It has been proposed that retained introns may render the
corresponding transcripts unstable that are possibly degraded by the nuclear or cytoplasmic RNA surveillance
complex (21,23). We reasoned that if intron-retained transcripts are unstable, they have to be transcribed at a higher
level to reach a steady-state mRNA level comparable to
those transcripts without IR (Supplementary Figure S6). To
test this hypothesis, we examined the transcriptional activities of genes with different levels of IR using Pol II ChIP-seq
signal. Two groups of genes were compiled based on their
IRI status: one group consists of top 1000 genes with the
highest IRI in resting T cells (IRI-high group), while the
other group consisted of the bottom 1000 genes with the
lowest IRI (IRI-low group). The IRI-high gene group had
significantly higher RNA Pol II occupancy than the IRIlow group (Figure 2A), suggesting that genes in the IRIhigh group are transcribed at a higher rate. The observation is further confirmed by an independent ChIP-seq experiment (Supplementary Figure S7). To rule out the possibility that the expression levels between these two gene
groups may affect the analysis, we further stratified the IRIhigh genes and IRI-low genes into 6 sub-groups to ensure
matching expression levels (Figure 2D and E). In every subgroup, although the steady-state mRNA levels are comparable, Pol II occupancy is significantly higher comparing IRI-high genes with IRI-low genes (P-value < 1E-45,
Mann–Whitney U test) (Figure 2F). The results were further corroborated by the occupancies of H3K36me3 (Figure 2B and G) and H4K20me1 (Figure 2C), which are two
histone variants known to spread over the promoter as well
as the gene body of transcribed loci (5,7). Taken together,
the higher transcriptional activity and comparable steadystate mRNA level strongly suggest that the intron-retained
transcripts tend to be less stable than those transcripts with
little or no intron-retention. Therefore, coupling of IR and
RNA degradation may regulate gene expression at the posttranscriptional level.
IR is broadly involved in regulated gene expression during human T cell activation
Since IR is significantly reduced upon T cell activation, we
then examined the potential link between IR and differential gene expression between resting and activated human T
cells. Intriguingly, we found that the reduction in IR is correlated with increased gene expression in a linear fashion (Figure 3A–F), thereby suggesting that regulated IR might play
an important role in controlling gene expression. To further
explore this notion, we focused on gene loci that were upregulated in activated T cells, reasoning that the increase in the
steady-state mRNA level might result from transcriptional
activation and/or post-transcriptional regulation (reduced
IR and increased RNA stability). Of the 2090 upregulated

genes, one fourth (507 genes or 24.3%) do not show significant reduction in IR (group I genes; Figure 4A left panel),
suggesting that they are likely to be predominately regulated
at the transcriptional level (Figure 4A). This is further confirmed by ChIP-seq results that show a significantly higher
Pol II level in activated T cells than in resting T cells (Figure 4A, left panel, Figure 4B, Supplementary Figure S8).
In contrast, the majority of upregulated genes (1583 genes
or 75.7%) showed a >2-fold reduction in intron retention
(Figure 4B), suggesting that regulated IR might serve as a
prevalent post-transcriptional gene regulatory mechanism.
We further divided the 1583 genes into two groups based
on whether there is a detectable change of the Pol II level
(group II, Figure 4A, middle panel) or not (group III, Figure 4A, right panel). Even for group II genes, the extent of
Pol II increase is less pronounced than group I genes (Figure
4A, comparing left and middle panel, Supplementary Figure S8), suggesting IR contributes to expression changes, although transcription activation and reduced IR might not
be mutually exclusive.
Proteasome genes are predominantly regulated by IR
To further pinpoint the biological significance of regulated
IR in human T cell activation, we focused on a subset of
up-regulated genes with reduced IRI, but no change in Pol
II levels, upon T cell activation. Thus, increase in gene expression is presumably due to more efficient splicing (or decreased intron retention) rather than elevated transcription.
A total of 185 genes were identified (group III genes in Figure 4A, Supplementary Table S1) and they are highly enriched in the proteasome pathway (P-value < 1E-7, Figure
4C), which is known to play a critical role in T cell proliferation and immune function (31,32). In contrast, group I
up-regulated genes (Figure 4A) are enriched in the IL-12
and IFN␥ signaling pathways (Supplementary Table S2),
consistent with transcription mediated gene up-regulation.
Inhibition of proteasome function in CD4+ T cells can result in cell cycle arrest, apoptosis and reduced cell proliferation (33). Proteasome inhibitors also lead to a decreased
production of CD25 and IFN␥ , two important markers for
T cell activation (34,35). Taken together, IR might be critical for T cell proliferation or activation by regulating the
steady-state mRNA level of proteasome related genes.
A subset of candidate proteasome genes was then randomly selected for validation. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used
to determine the expression level of the spliced and intronretained transcripts of each individual locus (Supplementary Figure S9, Supplementary Table S3 and S4). For all the
loci tested, IR was significantly reduced while the spliced
variant increased (Supplementary Figure S9B and S9C).
To further corroborate the findings, ChIP-PCR was used
to analyze the Pol II level at the promoter of PSMD7, one
of the proteasomal genes that is predominately regulated
at the post-transcriptional level based on the RNA-seq and
ChIP-seq results (Figure 5A). As expected, the Pol II level of
PSMD7 remained relatively constant between resting and
activated T cells (Figure 5A,F), although the level of spliced
mRNA variant and the protein level are significantly increased (Figure 5B–E, Supplementary Table S5). As a pos-
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Figure 2. IRI-high transcripts are less stable than IRI-low transcripts. (A), (B) and (C) show the RNA Pol II, H3K36me3 and H4K20me1 density profile,
respectively. The top 1000 genes (brown) and the bottom 1000 genes (blue) were selected based on their relative IRI ranks in resting T cells. The read counts
were normalized to uniquely mapped reads. Six pairs of gene groups were compiled with matched (D) expression profiles, the corresponding levels of (E)
intron retention, (F) Pol II, (G) H3K36me3 and (H) H4K20me1 are shown. In resting T cells, the median IRI values of IRI-high and IRI-low genes (E,
IRI values on the right-hand side) are 20.0% and 0.6%, respectively. ** and *** represents P-value < 0.01 and < 0.001, respectively.

itive control, the Pol II level of STAT1, a gene whose expression is up-regulated at the transcriptional level (36), is
increased upon activation (Figure 5F, Supplementary Table S5). By blocking a new round of transcription, expression of intron-retained and fully-spliced human PSMD7
transcript was assayed as a function of time. We found
that intron-retained transcript has a higher degradation rate
than its spliced counterpart (Figure 5G). To gain insight
into where IR occurs, cytoplasmic, nuclear and chromatinassociated fractions were isolated from resting human T
cells. qRT-PCR results showed a significantly higher level
of IR in nucleus than cytoplasm (Figure 5H). Interestingly,
chromatin-associated fraction has the highest level of retained introns (Figure 5H). This result indicates that IR oc-

curs co-transcriptionally and detained in nucleus, at least in
the case of the PSMD7 gene. Together, these data suggest
that proteasome-related genes might be predominantly regulated at the intron retention level during T cell activation.
Regulated IR is conserved in mouse CD4+ T cells
We next asked whether the observed IR-mediated gene regulation is conserved during evolution. To address this question, we analyzed IR using published mouse CD4+ T cell
transcriptome data (37). Similar to human T cells, IRI decreased in activated mouse T cells compared to naı̈ve T cells
(Figure 6). The mouse PSMD7 gene was used for further
validation and regulated IR can be confirmed, in mouse
T cells (Figure 6A and C). Interestingly, we observed that
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Figure 3. Changes in IR are negatively correlated with expression changes. (A) The fold changes in the IRI and expression levels were computed for each
expressed Entrez gene as the result of human T cell activation. Entrez genes were then evenly divided into 8 bins based on IRI fold changes (X axis). The
changes in expression levels for each gene in each group (Y axis) are shown as a box plot. (B) Both IRI fold-change rank (X axis) and expression fold
change rank (Y axis) of individual genes were evenly divided into 10 bins. Each Entrez gene was subsequently placed into one of the 10 × 10 grids. The
enrichment scores (Z score) were computed based on the observed gene density in each grid compared to a random distribution, and collectively shown
as a heat map. Spearmen’s rank correlation value is -0.43, with a P-value < 1E-300. (C–F) show four gene loci with a decreased IR level (left panel) and an
increased transcript abundance (right panel) upon T cell activation.

the reduction of IR ratio (and the increase in gene expression) takes place in a time-dependent manner, and that the
changes in IR level became apparent 8 h after cell activation (Figure 6B). These data strongly suggested that gene
expression regulation via IR is evolutionary conserved.
DISCUSSION
In this study, we showed that IR is prevalent in resting
human CD4+ T cells and the level of retained introns is
dramatically reduced upon activation (Figure 1). Majority
(75%) of up-regulated genes in activated T cells exhibit a decrease in IR. The rest of the up-regulated genes, for which
intron retention is not reduced, do show a more pronounced
increase of Pol II levels at the promoter region (Figure 4A).
These results explain at least in part the lack of concordant

changes of Pol II occupancy and histone modifications for
differentially expressed loci (Supplementary Figure S1). Extending the previous reports (19,23), we provided evidence
that intron-retained transcripts are unstable and subject to
RNA degradation (Figures 2 and 5G). Therefore, regulated
IR coupled with RNA instability might serve as a novel
post-transcriptional mechanism to control gene expression
duering T cell activation (Figure 7).
The hallmark of an adaptive immune system is its ability
to rapidly tune gene expression levels and cellular functions
in response to specific stimuli. Transcriptional regulation
has been extensively studied in T cell activation (38–40). Interestingly, we identified 185 up-regulated genes that show a
concomitant decrease in IR without significant alterations
of Pol II levels (Figure 4). These data highlighted that IR
may drive differential gene expression in a transcription-
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Figure 4. Upregulated expressions in activated T cells are mediated by transcriptional activation and/or intron retention. (A) A total of 2090 up-regulated
genes identified by RNA-seq were initially divided into 2 groups based on their IRI changes. Group I consists of 507 genes that did not exhibit a decrease
in intron retention. The rest of genes (1583 genes) were further divided into two groups (groups II and III) based on the Pol II ChIP-seq data obtained
from resting and activated CD4+ T cells. Group III genes (185 genes) show little or no change in Pol II occupancy (<30% change) and expression fold
change > 3, while group II contains the remaining 1398 genes. Aggregated Pol II profiles of each group including 5 kb upstream of the transcription start
sites (TSS) and 5 kb downstream of the transcription end sites (TES) are shown. (B) The distribution of the IRI fold-changes of three gene groups between
resting and activated T cells. (C) Gene Ontology (GO) analysis of group III genes and the proteasome complex emerged as the most significant pathway
(P-value < 1 × 10−7 ).

independent manner, although the two mechanisms are not
necessarily mutually exclusive. Of these 185 genes, transcripts encoding subunits of the proteasome complex are
highly enriched that is critical for T cell proliferation and cytokine release (33,34,41). We speculate that IR may provide
an alternative way to achieve coordinated gene expression,
similar to previous reports on fission yeast (42), budding
yeast (26) and mammals (18–21,23).
Emerging studies have shown that IR is a widespread
phenomenon in diverse tissues and cell types, and that the
level of IR is often progressively increased during development, cell differentiation and terminal erythropoiesis (19–
21,23). It has been proposed that IR may function to further repress low abundant transcripts to prevent leaky expression during cell or tissue specification (19). Extending
these observations, our study demonstrated that IR is actively regulated upon acute T cell activation in both human
and mice. Therefore, native T cells and possibly other terminally differentiated cells (e.g. neurons) may reach an ‘active quiescent’ state, and IR in a subset of genes may bet-

ter prepare the cells for future encountering with pathogens
or other stimuli. Compared to transcription activation, elevated gene expression from reduced IR levels does not necessarily require new rounds of transcription, thereby shortening the response time to stimuli. This can potentially be
achieved by directly converting intron-retained transcripts
into productive mRNAs by splicing machinery (43,44). It
is well established that the activities of splicing factors (SR
proteins and hnRNPs) are subject to the regulation of signaling cascade and may subsequently facilitate such splicing
fate transition (45,46).
It is worth noting that the percentage of IR detected by RNA-seq or RT-PCR is at steady-state. Liu
lab provided evidence that histone modifications such as
H3K36me3, H3K4me3 and H3K27me3 can reflect transcriptional activity and are thus able to predict mRNA stability (47), supporting our hypothesis that mRNAs have
higher H3K36me3, Pol II and H4K20me1 signals but comparably steady-state expression levels are less stable than
mRNAs that have lower ChIP-seq signal (Figure 2B–D).
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Figure 5. The expression of PSMD7 gene is predominantly regulated by IR during human T cell activation. (A) The strand-specific RNA-seq (top two
panels) and Pol II ChIP-seq (bottom two panels) tracks of the PSMD7 gene. Three representative introns that have changed retention ratio between
resting and activated human T cells are shown in dashed rectangles. (B) RT-PCR validation of regulated IR at the PSMD7 locus. Total RNA isolated
from resting and activated human CD4+ T cells was reversely transcribed using oligo(dT) primer. The first-strand cDNAs were then amplified with three
primers specific for PSMD7 transcripts. The expected amplification products are shown as indicated. (C) The spliced transcript abundance and (D) IR
level of human PSMD7 gene were subsequently determined by quantitative RT-PCR (qRT-PCR) with primer pairs specific for spliced and intron-retained
transcripts, respectively (mean ± SE, n = 3; two-tailed Student’s t-test). *** and ** stands for P-value < 0.001 and < 0.01, respectively. (E) Western Blot
for PSMD7 protein in resting (R) and activated (A) human CD4+ T cells. ␤-tubulin serves as internal control. (F) ChIP-PCR analysis of Pol II occupancy
at the promoter regions of PSMD7 and STAT1 genes, respectively (mean ± SE, n = 3; two-tailed Student’s t-test). STAT1, a known transcriptionally
regulated gene, was used as a positive control. (G) The degradation rate of spliced and intron retained transcript of PSMD7 gene was quantified by qRTPCR after inhibition of new round of transcription by adding Flavopiridol (FLV, 1 M) in human resting T cells over the time course (min) shown in the
figure. (H) The relative IR level (intron-retained versus spliced) of PSMD7 gene was determined by qRT-PCR of RNA derived from cytoplasmic (Cyto),
nuclear (Nuc) and chromatin-associated (Chro) fractions in human resting T cells. *** represents P-value < 0.001 (two-tailed Student’s t-test).

6826 Nucleic Acids Research, 2016, Vol. 44, No. 14

Figure 6. Conservation of IR-mediated gene regulation in mouse CD4+ T cells. (A) The RNA-seq tracks of the PSMD7 gene obtained from mouse naı̈ve
CD4+ T cells, and Th1 cells 8 h, 12 h and 24 h post- activation. Two representative introns that have changed retention ratio are shown in dashed rectangles.
(B) The overall IRI distribution of naı̈ve and activated mouse Th1 cells. (C) RT-PCR validation of reduced IR at the mouse PSMD7 locus along the course
of Th1 cell activation. Actb1 serves as the internal control, which didn’t show significant expression changes for 4 different conditions. Ccl4 gene serves as
a positive control for mouse T cell activation.

Figure 7. Proposed model for IR regulates steady-state mRNA level in both human and mouse CD4+ T cells. In resting T cells, a certain number of
genes (such as proteasome related genes) were not efficiently spliced that leads to high degree of degradation, possibly via the exosome-mediated pathway. Upon activation, splicing becomes more efficient and intron retained transcripts could be converted into productive mRNAs (Dashed line with an
arrowhead). Therefore, an increase in steady-state mRNA level does not necessarily require transcriptional activation and could be solely achieved at the
post-transcriptional level. ‘TF’ and ‘Enh’ is the abbreviation for ‘transcription factor’ and ‘enhancer’, respectively.
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Our data suggest that intron-retained transcripts have a
higher turnover rate than intron-spliced isoforms. Therefore, it is plausible that the actual fraction of intron-retained
transcripts produced by transcription is much higher than
the observed fraction, especially in resting T cells. Consequently, changes of IRI could have significant impacts
on steady-state gene expression by stabilizing otherwise degraded transcripts (Figure 5 and Supplementary Figure
S7). Methods such as GRO-seq, Bru-seq and BruChaseseq (48,49), which measure the Pol II on-rate, nascent transcription and transcript turnover; respectively, are expected
to help further elucidate the mechanism underlying IRmediated gene regulation.
To address whether every intron along the transcript has
similar retention levels, we computed the IRI for individual introns and grouped them into five categories based on
their relative locations. Consistent with previous observations (50), IR levels gradually increase in a 5 to 3 orientation except the first intron, which on average has the highest
retention level (Supplementary Figure S10). Furthermore,
the fraction of intron retention of each category was significantly reduced upon T cell activation (Supplementary
Figure S10), suggesting that there is no obvious location
bias. To address whether specific intron(s) are selectively retained in individual genes, we focused on genes containing 6 or more shared introns, and determined the number
of retained introns in each gene using different IRI cutoffs
(Supplementary Figure S11). The results showed that genes
with only one retained intron represent the most abundant
IR class regardless of the IRI cut-offs used. As the number of retained introns required for each group increases,
the group size gradually decreases (Supplementary Figure
S11). Similar trends were observed in both resting and activated human T cells using all genes (Supplementary Figure
S11A and B; based on shared introns and exons) and only
the simple genes (or genes without any alternative isoform)
(Supplementary Figure S11C and D). This observation suggests that transcripts with a single IR event may exist, although a considerable proportion of IR transcripts contain
two or more introns. These results are consistent with recent
studies that suggest specific introns might be preferentially
retained (18,23,44).
It has been shown that retained introns are often associated with higher G/C content, reduced intron length
and relatively weak splice site signals (19). Interestingly, we
found that the overall gene length, compared to the intron
length, may be more reliable in predicting IR in T cells (Supplementary Figure S12). In addition, the RNA Pol II elongation rate and pausing over exonic/intronic regions has
been suggested to be associated with exon definition and
splicing efficiency (19,51–55). We speculate that IR may reflect temporal competition between splicing and transcription during co-transcriptional splicing (50,56). Therefore, it
may be necessary to include time as an important variable
when investigating IR and other alternative splicing events.
The situation is further confounded by chromatin states
(e.g. histone modifications) that play direct or indirect roles
in regulating transcription (57) and splicing (58,59). Further
mechanistic characterizations are warranted for a better understanding of regulated IR as well as its potential coupling
with transcriptional and post-transcriptional regulations at

the systems level. Lynch lab and others showed that activation of T cells is characterized by a robust change in the
alternative exon splicing program (60–62). These studies together with our results underscore that RNA processing is
substantially regulated at both the exon and intron levels
during T cell activation.
Recent studies have revealed a broad involvement of IR
in development and cell differentiation. Our results further extend its role in regulating gene expression during
CD4+ T cell activation. Our data highlight that IR, in combination with RNA degradation, serves as a novel posttranscriptional mechanism broadly involved in gene expression regulation in CD4+ T cells and beyond.
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